0
Just Say No, Part 77
May 2, 2026
Posted 59 minutes ago by
This is low, even for them: Test strips used to determine if illicit drugs contain deadly contaminants including fentanyl will no longer be covered by federal funding, reversing a position the Trump administration held as recently as July and leaving public health organizations worried that the U.S. will lose the progress it has made combatting fatal overdoses.
In a letter reviewed by CBS News, the Substance Abuse and Mental Health Services Administration said that agency funding cannot be used to purchase test strips used to check drugs for dangerous adulterants like fentanyl, xylazine and medetomidine. Test strips cost about 1 each and can be used to check drugs — from powders to pills to party drugs — for contamination. They are a “critical, life-saving tool” that can prevent fatal overdoses, said Maritza Perez Medina, director of federal policy at the Drug Policy Alliance. Medina said the sudden change in policy has left advocates scrambling. “People are just astonished,” Medina said. “There has been a lot of confusion about where this came from.” The “Dear Colleague” letter references an executive order signed by President Trump in July 2025 that declares SAMHSA funding cannot be used for programs that “only facilitate illegal drug use.” A Health and Human Services spokesperson said that the letter clarifies guidance for SAMHSA grantees and furthers the agency’s clear shift away from harm reduction and “practices that facilitate illicit drug use and are incompatible with federal laws.” These strips have saved many lives. But the Trump administration, which just loosened laws on certain
Digby's Hullabaloo
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.